Frontiers in Cardiovascular Medicine
Overview
Frontiers in Cardiovascular Medicine is a peer-reviewed journal dedicated to advancing knowledge and understanding of cardiovascular diseases and their management. It publishes high-quality research articles, reviews, and clinical studies that explore innovative approaches, diagnostic tools, therapeutic interventions, and preventive strategies in the field of cardiovascular medicine. The journal aims to foster collaboration among researchers, clinicians, and policymakers to improve patient outcomes and promote cardiovascular health worldwide.
Details
Details
Abbr.
Front Cardiovasc Med
Start
2014
End
Continuing
e-ISSN
2297-055X
Country
Switzerland
Language
English
Specialty
Cardiology & Vascular Diseases
Metrics
Metrics
h-index / Ranks: 5213
69
SJR / Ranks: 4728
863
CiteScore / Ranks: 9425
2.60
JIF / Ranks: 2654
3.6
Recent Articles
1.
Richert E, Grefen L, Zorin A, Hubrich J, Simon S, Sommerhoff C, et al.
Front Cardiovasc Med
. 2025 Mar;
12:1540826.
PMID: 40083825
Objective: Despite advancements in surgical techniques, many patients born with congenital heart defects (CHD) require repeated reinterventions due to the limitations of materials used in congenital cardiac surgery (CCS). Traditional...
2.
Narasimhan M, Cao J, Meeusen J, Remaley A, Martin S, Muthukumar A
Front Cardiovasc Med
. 2025 Mar;
12:1534460.
PMID: 40083824
No abstract available.
3.
Miaomiao S, Jiaqi Z, Xiaomeng L, Shanshan L, Jie W, Kaicheng L, et al.
Front Cardiovasc Med
. 2025 Mar;
12:1451173.
PMID: 40083823
Background: Myocardial intramural course (MIC), a benign anatomical lesion, is an abnormal anatomical structure formed due to abnormal blood vessel routing. An increasing number of studies indicate that MIC is...
4.
Liu C, Zheng F, Gao Y, Wang Z, Zhang X, Tian X
Front Cardiovasc Med
. 2025 Mar;
12:1518000.
PMID: 40083822
Background: Hypertrophic cardiomyopathy (HCM) is an autosomal dominant disorder characterized by asymmetric hypertrophy of the ventricles and the ventricular septum, leading to subsequent left ventricular outflow tract (LVOT) obstruction and...
5.
Wu R, Zhang Y, Yuan X, Yan X, Fu X
Front Cardiovasc Med
. 2025 Mar;
12:1489382.
PMID: 40083821
Background: Previous studies have shown that exercise can improve arterial stiffness (AS). However, it remains unclear which type of exercise is most effective for managing AS, particularly in individuals at...
6.
Li L, Xie B
Front Cardiovasc Med
. 2025 Mar;
12:1513942.
PMID: 40083820
Background: Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia worldwide, posing significant health burdens. Pulsed field ablation (PFA) is an emerging non-thermal technique that is gaining traction due to...
7.
Wu Y, Zhang Y, Zheng Q, Wang Q, Fang X, Zhu Z, et al.
Front Cardiovasc Med
. 2025 Mar;
12:1529921.
PMID: 40083819
Introduction: Mutations in the sarcomere protein, particularly in cardiac myosin binding protein C gene (), were the most frequent genetic cause of hypertrophic cardiomyopathy (HCM). The pathogenic MyBPC3 P459fs mutation...
8.
Liu C, Ma Y, Qiao S, Li K, Qi M, Gu C, et al.
Front Cardiovasc Med
. 2025 Mar;
12:1462263.
PMID: 40083818
Background: SARS-CoV-2 antibody positivity, whether due to natural infection or vaccination, is known to be associated with specific cardiac and vascular damage, yet its impact on cardiac structure and function...
9.
Guan J, Xu Y, Liu L, Su M, Ma J
Front Cardiovasc Med
. 2025 Mar;
12:1520696.
PMID: 40083817
Purpose: To evaluate the prognostic value of Low-density lipoprotein receptor-related protein 1 (LRP1) in patients with acute ST-segment elevation myocardial infarction (STEMI) following percutaneous coronary intervention (PCI). Method: This prospective...
10.
Zhang W, Guo T
Front Cardiovasc Med
. 2025 Mar;
12:1488503.
PMID: 40078460
Giant cell myocarditis is a rare and rapidly progressive disease with a high mortality rate. We present the case of a 21-year-old male without a medical history who presented with...